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Abstract 
Direct supersonic steam injection, direct steam infusion, and indirect tubular heating were 
each applied to protein-enriched skim milk-based beverages with 4, 6 and 8% (w/w) total 
protein, and the effect of final heat temperature on the physical properties of these beverages 
was investigated. Supersonic steam injection resulted in significantly lower levels of 
denaturation of β-lactoglobulin (34.5%), compared to both infusion (76.3%) and tubular 
(97.1%) heating technologies. Viscosity, particle size and accelerated physical stability of 
formulations did not differ significantly between the heating technologies, while noticeable 
colour differences due to heat treatment (mainly attributed to increasing b* value) were 
observed, particularly for tubular heating. Overall, the extent of protein denaturation in high-
protein dairy products was significantly influenced by the particular heating technology 
applied. The application of supersonic steam injection technology, with rapid heating and 
high shear characteristics, may enable differenciated product characteristics for ready-to-
drink ambient-delivery high-protein dairy beverages. 
Industrial Relevance 
The design and application of novel direct supersonic steam injection technology was 
comprehensively studied and found to provide significant benefits over direct steam infusion 
and indirect tubular heating technologies for skim milk-based protein beverages. This type of 
injection heating system resulted in heat-treated formulations with lower levels of denatured 
whey proteins, compared to tubular and infusion heating, offering an alternative opportunity 
to the industry in terms of producing shelf-stable dairy protein beverages. 
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1. Introduction 
Extended shelf life (ESL) and ultra-high temperature (UHT) treated milk have increased in 
popularity worldwide, providing long shelf-life and eliminating cold chain requirements, 
thereby reducing economic costs to producers, distributors and consumers (Bertolini et al., 
2016, Malmgren et al., 2017). High-heat dairy treatments, like ESL heating (120-135 °C for 
2-4 s) and UHT (135–145 °C for 2-4 s), can negatively impact the nutritional quality and 
sensory properties of the final product due to the severity of the heat treatment applied. In 
addition, the choice of thermal processing technology used to achieve ESL or UHT treatment 
can have a significant impact on physical properties and consumer acceptability of the final 
product (Deeth and Lewis, 2016; Roux et al., 2016).  
Thermal processing technologies may be classified as direct or indirect, which have different 
heat transfer mechanisms. For indirectly heated systems, heat is transferred from the heating 
medium to the product through a thermally conducting but otherwise impermeable barrier, 
while direct heating achieves almost instantaneous heating through the direct addition of the 
heating medium, steam, to the product (Hsu, 1970; Burton, 1994; Schroyer, 1997; Lewis et 
al., 2000). Direct heating imparts a lower thermal load on the product due to significantly 
faster heating and cooling rates, thereby reducing thermally-induced changes in the final 
product (Kelleher et al., 2018b). However, there are challenges associated with direct systems 
such as the requirement for culinary-grade steam, lower heat regeneration capacity, and 
concerns with product dilution, resulting in indirect technologies being more commonly used 
industrially (Datta et al., 2002; Britz and Robinson, 2008; Dickow et al., 2012b; 
Karayannakidis et al., 2014; Lee et al., 2017).     
Traditional direct technologies, such as steam injection and infusion systems, have been 
available for decades and their use with various dairy products has been investigated 
throughout the years (Ford et al., 1969; Patrick and Swaisgood, 1976; Lyster et al., 1971, 
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Datta et al., 2002, Dumpler and Kulozik, 2016). Over the years there have been engineering 
improvements and reconfigurations made to the original formats, such as the lenient steam 
injection patented process (Dickow et al., 2012a, Dickow et al., 2012b) or supersonic steam 
injection (Murphy, 2011, Murphy et al., 2013). There has been little investigation into the 
application and potential benefits of supersonic steam injection to dairy products. This study 
used a patented supersonic steam injector (Maklad Fluid GmbH), which makes use of a De 
Laval nozzle to achieve better mixing and potentially attaining supersonic flow within the 
injection unit. These nozzles are commonly referred to as converging-diverging nozzles, 
where an inlet section converges into a narrow throat and subsequently expands into a 
divergent outlet (Canosa et al., 2016). The converging inlet accelerates the fluid, in this case a 
mixture of steam and liquid product, until the flow becomes choked or sonic at the throat, 
where the cross-sectional area is smallest, and a Mach number (Ma) of 1 is achieved. Due to 
conservation of volumetric flow, temperature and pressure reduce with increasing area in the 
diverging outlet, thereby increasing kinetic energy and resulting in supersonic flow (Ma > 1). 
The application of a supersonic steam injector in dairy processing can theoretically produce 
better product mixing due to high shear from (i) the high throat velocities and (ii) the 
shockwave produced, with reduced residence time in the injection chamber, compared to 
traditional direct systems in dairy processing (Murphy et al., 2011; Murphy et al., 2013). 
   
Increased consumer awareness has led to market demands for healthy, protein-enriched foods 
for general consumption, in addition to clinical uses such as for the treatment of malnutrition, 
sarcopenia in the elderly, high-performance sports nutrition, and body-building (Hayes et al., 
2008; Jelen, 2009; Shiby, 2013; Withers et al., 2014; Chen and O’Mahony, 2016). Milk 
proteins have many health-promoting and nutritionally beneficial properties for the 
consumer, such as supplying essential amino acids for tissue growth and repair, metabolic 
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regulation for weight control, and anti-oxidant functions for immune-enhancing properties 
(Beucler, 2005; Smithers; 2008; Wijayanti et al., 2014; Gupta and Prakash, 2015). However, 
protein-enriched beverages can pose thermal processing challenges, particularly in relation to 
the denaturation, aggregation and fouling of heat-labile dairy proteins, with the selection of 
thermal processing technology having a significant impact on the occurrence of these 
phenomena (Joyce et al., 2017; Kelleher et al., 2018). The nutritional value of proteins can be 
impaired by severe heat treatment, resulting in decreased protein digestibility and the 
availability of substrate to enzymatic digestion (Resmini et al., 2003). ‘Cooked’ off-flavours 
commonly associated with ESL and UHT milks are connected to the level of whey protein 
denaturation, particularly β-lactoglobulin, as free sulfhydryl groups are exposed leading to 
the development of sulphur compounds in the milk (Al-Attabi et al., 2009; Zabbia et al., 
2012; Lee et al., 2017). Incorporation of ingredients can also pose challenges in high protein 
beverage systems, with commonly used powder ingredients such as milk protein concentrates 
(MPC) exhibiting poor solubility. The application of high temperatures, shear and increased 
hydration time can improve MPC solubility and incorporation into beverage formulations 
(Pathania et al., 2018). Novel thermal processing technologies may prove to be important 
tools for the food industry in the development of protein-enriched beverages with 
differentiated physical properties which can satisfy changing market demands.   
The aim of this study was to investigate the impact of direct supersonic steam injection 
heating on the physical characteristics of ready-to-drink protein-enriched dairy-based 
beverages with ambient distribution, compared to standard direct infusion and indirect tubular 
heating technologies. The three heating technologies were applied to beverages having three 
different protein levels, operated at three final heat treatment temperatures, and compared in 
terms of final product quality and stability.  As little has been published in relation to the use 
of supersonic injectors in dairy processing, the focus of this study was to determine the 
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implications of high shear and rapid heat transfer during processing using the supersonic 
injector and analysing for protein denaturation, and beverage viscosity and physical stability.     
2. Materials and methods 
2.1. Materials and formulation 
Medium-heat skim milk powder, SMP (33.93 % protein, 0.78 % fat, 6.04 % moisture, 48.88 
% lactose and 8.13 % ash), and milk protein concentrate, MPC80 (83.03% protein, 0.96% fat, 
4.03 % moisture, 3.99 % lactose and 6.96 % ash) were supplied by Glanbia Ingredients 
Ireland Ltd. (Kilkenny, Ireland).  
Model protein-enriched beverages were formulated at 4, 6 and 8 % w/w protein 
concentrations using a skim milk base, reconstituted to 10 % total solids (w/w) in reverse 
osmosis water at 45 °C using a YTRON ZC powder induction unit (YTRON Process 
Technology GmbH, Bad Endorf, Germany). MPC80 was added to each formulation to yield 
desired protein concentration (0.73, 3.14, 5.55 % MPC80 (w/w) for 4, 6 and 8 %, 
respectively) and inducted with a high shear mixer (Silverson EX, Silverson Machines Ltd, 
UK). The formulations were held overnight in stirred tanks at 4 °C to allow for powder 
hydration. The pH was measured before and after overnight storage and was adjusted to pH 
6.7 using 0.1 M HCl or KOH, if required.  
2.2. Heat Treatment  
Three types of heat treatment technology were applied to the formulations: direct steam 
infusion, direct supersonic steam injection, and indirect tubular heating (Fig. 1). All heat 
treatment conditions consisted of a preheat treatment (70 °C for 30 s) and final heat treatment 
(121, 135 or 142 °C, for 3 s) with a flowrate of 100 L/h. Infusion heating employed a UHT 
pilot-scale plate exchanger Model 422463 (APV, Denmark), and as in the injection system, 
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initial cooling to 70 °C was achieved using vacuum flash cooling. Preheat and final cooling 
operations were carried out using plate heat exchangers. Indirect tubular heating was applied 
using a MicroThermics tubular UHT 25HV pilot plant (MicroThermics, NC, USA), 
consisting of four tubular heat exchangers; preheat, final heat and two cooling exchangers. 
The direct steam injection was achieved by integrating a purpose-built process line with a 
Maklad supersonic injector Model 700-143-60 (Maklad Innovative Fluid- and Systemtechnik 
GmbH, Austria) for final heat treatment into the MicroThermics plant (Fig. 1B). The process 
line consisted of the Maklad injector, flash cooler, condenser, vacuum pump, product pump, 
culinary steam and product filters and an independent cleaning-in place (CIP) system. 
Vacuum flash cooling to 70 °C was applied after final heat treatment as part of the injection 
process line, while tubular heat exchangers from the Microthermics systems were used for 
preheating and final cooling operations. The injector had a de Laval converging-diverging 
nozzle with a flow rate range of 50 – 150 L/h for the steam-product mix and had a Teflon 
coating in the steam-product mixing zone to reduce burn-on. All heat treatment trials were 
carried out in triplicate.  
2.3. Protein analysis 
Total protein content was determined using the Kjeldhal method with a nitrogen-to-protein 
conversion factor of 6.38 (IDF, 2001). Native protein levels were determined using reverse-
phase high-performance liquid chromatography (RP-HPLC) equipped with a Waters 2695 
separation module, Waters 2487 dual wavelength absorbance detector at 214 nm and 
Empower
®
 software (Milford, MA, USA). The HPLC was equipped with a PolymerX 5µm 
RP-1, 150 x 4.6 mm column (Phenomenex, Cheshire, UK). α-Lactalbumin (α-la), β-
lactoglobulin A and B (β-lg A and B) standards (Sigma Aldrich, Ireland) were used to 
calibrate the method. Sample preparation required pH adjustment to 4.6 with 0.1 M acetate 
buffer to 2.5 g/L protein, centrifugation at 20,000 g for 20 min at 4 °C, and filtration of the 
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supernatant using 0.2 µm PES filters (Agilent Technologies, Santa Clara, CA, United States) 
(Kehoe et al., 2011; Kelleher et al., 2018). Total solids content was measured using a Smart 
System 5, Smart Trac (CEM Corporation, Matthews, NC, USA). 
2.4. Viscosity 
Viscosity was determined using a shear rate sweep at 25 °C, using an AR-G2 controlled 
stress rheometer (TA Instruments, Crawley, UK) with a concentric cylinder geometry 
(Murphy et al., 2013). The apparent viscosity values presented are the average viscosity on 
holding at 500 1/s for 1 min. 
  
2.5. Particle size 
A Malvern Zetasizer Nano ZS combined dynamic light scattering analyser (Malvern 
Instruments Ltd., UK) was used to determine particle size at 25 °C. Samples were dispersed 
using ultra-pure water in polystyrene disposable cuvettes with refractive index for protein and 
the water dispersant of 1.45 and 1.33, respectively. Particle size is reported in terms of 
intensity mean (d.nm).    
2.6. Colour analysis 
Colour of samples in disposable cuvettes was measured using a Minolta Chroma meter CR-
400 colorimeter (Minolta Ltd., Milton Keynes, UK) and expressed in L*, a* and b* values.  
Colour difference from unheated formulations, ΔE, was determined using the CIE76 
Euclidean distance formula, given as described by (Morales and Jiménez-Pérez, 2001): 
       
    
       
    
       
    
                2.1 
2.7. Accelerated physical stability  
Accelerated physical stability of formulations was investigated using a LUMiSizer analytical 
centrifuge (Lum GMBH, Berlin, Germany), equipped with SepView 4.1 software. Samples 
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(0.4 mL) were filled into PC100-131XX polycarbonate cells to a 20 mm depth and 
centrifuged at 2300 g for 3 h at 25 °C (Chen and O’Mahony, 2016). The software integrates 
with respect to particle position on each transmission profile to characterise instability over 
time as a second order polynomial. To calculate the change in transmission over time, 
integration limits were set along the length of the filled tube, at 110 to 130 mm. The average 
slope of this polynomial, calculated from the polynomial coefficients, was used as an 
instability index to compare the stability of different samples under accelerated conditions.  
2.8. Statistical analysis 
Heat treatment trials were carried out in triplicate. The Minitab
®
 17 (Minitab Ltd., Coventry, 
UK) statistical analysis package was used to carry out one-way ANOVA with Tukey post hoc 
and three-way ANOVA analysis using protein content, heating technology and heat treatment 
temperatures as factors.  
3. Results and discussion 
3.1. Protein and total solids analysis  
Total solids and total protein were analysed before and after heat treatment and steam 
injection and tubular heat treatment did not significantly differ in their effects on the level of 
total solids and total protein for 4, 6 and 8 % (w/w) protein formulations (Table 1). However, 
steam infusion technology resulted in a significant reduction in total solids and protein levels 
at each protein concentration and treatment temperature applied (p < 0.001). It is likely that 
the reductions in solids content following steam infusion are related to product dilution by the 
condensed steam heating medium, due to incomplete removal of water by flash cooling, 
which is commonly reported for pilot-scale operation of direct heating systems,  (Dickow et 
al., 2012a; Dickow et al., 2012b; Murphy et al., 2013; Dumpler et al., 2017). The application 
of injection and tubular heating resulted in no significant change in total protein content being 
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observed and while infusion treatment affected the level of total protein in the final 
formulation (possibly due to fouling), injection heating did not. 
The level of native protein was significantly affected by the type of heating technology, 
protein concentration and temperature applied (p < 0.001, p < 0.001 and p < 0.05, 
respectively). The concentrations of native α-la were most greatly reduced by tubular heating, 
resulting in a final native α-la content that was 11.7 - 55.9 % of the initial content in unheated 
formulations. Both direct injection and infusion heating resulted in significantly less 
denaturation of α-la, compared to tubular heating. For infusion technology, treatment at 121 
°C did not affect the level of native α-la at any concentration (p > 0.05), while higher 
temperatures (135 and 142
 
°C) resulted in a reduction in levels of native α-la (on average 65.8 
% native α-la from the initial content; p < 0.05). Injection heating resulted in the lowest level 
of α-la denaturation of all technologies investigated, with no significant change in native α-la 
level (on average 82 % native α-la from the initial content; p > 0.05) despite the application 
of high temperatures, with the exception of the treatment at 135 °C for the 4 % w/w protein 
formulation (with 71 %
 
native α-la from the initial content; p < 0.05).  
Despite extensive denaturation of β-lactoglobulin (β-lg) for all heat treatments, significant 
differences between heating technologies were evident (Fig. 2). Injection heating resulted in 
heat-treated formulations with significantly greater levels of native β-Lg A and B, compared 
to tubular and infusion heating (p < 0.001). The average levels of native β-lg A and B were 
greater after injection (64.7 and 66.4 %, respectively) compared to tubular heating (3.16 and 
2.72 %, respectively), indicating substantial denaturation with the use of indirect tubular 
heating. For 4 % (w/w) protein formulations, the differences between infusion and tubular 
heating were statistically significant (p < 0.05); however, at higher protein concentrations, 
these differences were not significant.  
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While both infusion and injection systems resulted in higher levels of native protein than 
indirect tubular heating, supersonic injection technology resulted in the lowest whey protein 
denaturation levels at high processing temperatures. This may be due to the accelerated 
product flow within the injector chamber for supersonic injection, allowing the required heat 
to be imparted with reduced residence time, reduced thermal load and more uniform 
temperature (Murphy et al., 2011; Murphy et al., 2013). The application of high levels of 
shear, due to shockwaves produced in the supersonic injection system, may also contribute to 
the lower levels of protein denaturation observed. It has been shown that high shear can 
reduce whey protein aggregate formation leading to greater retention of native protein post 
heat treatment (Dissanayake and Vasiljevic, 2009; Çakır-Fuller, 2015; Wolz et al., 2016). 
Reduced degree of β-lg denaturation have been shown to reduce the levels of ‘cooked’ off 
flavours and sulphur volatiles in milk (Lee et al., 2017; Kelleher et al., 2018b). The 
substantially lower levels of denatured whey protein in injection-heated formulations is a 
significant differentiating attribute (e.g. with respect to sensory, colloidal stability and protein 
quality) for the final product, compared to infusion- and tubular-heated formulations.  
3.2. Viscosity 
While beverage viscosity increased with increasing protein and total solids content (p < 
0.001), heat-treated formulations were not significantly affected by heating technology or 
temperature per se (p > 0.05; Table 1).  For 4 and 6 % (w/w) protein formulations, viscosity 
was not significantly affected by heat treatment using infusion, injection or tubular heating. 
Heat treatment significantly reduced the viscosity of 8 % (w/w) protein formulations in all 
cases, by an average of 28.4 % (p < 0.05) relative to the unheated formulation, with no 
significant effect of increasing heat treatment temperature or technology. This reduction in 
viscosity may be due to increased solubilisation of the added MPC powder at the high heat 
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treatment temperatures for the more concentrated 8 % (w/w) protein formulation as reported 
by Pathania et al. (2018). 
3.3. Particle size 
The average particle size for 4 and 6 % (w/w) protein formulations was not significantly 
affected by heat treatment (p > 0.05; Table 1). For 8 % (w/w) formulations, the unheated and 
injection 142 °C heated formulations resulted in the greatest particle size. This increase in the 
unheated formulation is likely due to the dissolution of MPC, an ingredient which is 
notoriously difficult to fully solubilise under standard processing conditions (McCarthy et al., 
2014). With the application of heat treatment and, in the case of steam injection, shear 
effects, solubilisation of the MPC is improved and the average particle size is reduced for 8 
% (w/w) formulations. 
While, overall, the average particle size did not differ significantly between heating 
technologies for most protein formulations, differences in particle size distribution were 
observed (Fig. 3). Injection heating resulted in a broader size distribution than infusion and 
tubular heating, for each treatment temperature and protein concentration. The high levels of 
shear produced by the supersonic injector may be the cause of the broadening distribution, as 
the degree of protein aggregation is reduced, and a higher quantity of smaller soluble 
aggregates are present in the system (Wolz et al., 2016).   
3.4. Accelerated storage stability  
The level of protein had a significant impact on stability of formulations, with increasing 
protein concentration resulting in improved accelerated storage stability (Fig. 4). This is 
likely due to the increase in viscosity with increasing protein concentration (Table 1) 
(Karlsson et al., 2005; Lim and Roos, 2015). As with viscosity and particle size, there was no 
significant difference in accelerated storage stability of unheated, infusion-heated, tubular-
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heated or injection-heated formulations at any protein concentration (p > 0.05), while there 
were consistent trends for those parameters across protein levels 
3.5. Colour analysis 
The protein content of formulations was found to have a significant effect on the lightness, 
L*, which increased in unheated formulations as the total solids and protein content increased 
(p < 0.001; Table 2). The L* value is largely attributed to particle size and total solids; 
therefore, as the level of casein micelles increases with protein concentration the L* value 
increases for the unheated formulations (Chung et al., 2014). Heating technology had a 
significant effect on L* values of formulations (p < 0.001), with tubular heating resulting in a 
higher L* value for all 6 and 8 % protein formulations compared to other heating 
technologies. Similar L* values were obtained for the 4, 6 and 8 % protein formulations using 
infusion and injection direct heating systems (Table 2).  
The a* value (red-greenness) of beverages generally increased upon heat treatment, an effect 
that become more significant with increasing protein concentration (p < 0.001). At 4 % 
protein, significant increases in a* value were identified for infusion treatments at 121 °C and 
135 °C and tubular treatment at 142 °C only (Table 2). Heating technology and temperature 
were shown to affect a* value (p < 0.01 and 0.05, respectively), with tubular heating causing 
the greatest increase. Changes in a* value increased with increasing heating temperature. 
There was no significant difference between a* values following injection and infusion for 
the protein concentrations investigated.  
The b* value increased with increasing protein concentration (Table 2). Heat treatment had a 
significant impact on the b* value, with infusion resulting in the lowest b* value and tubular 
treatment resulting in the highest b* value overall (p < 0.001). Tubular and injection heating 
significantly increased the b* value with increasing temperature, while infusion did not. For 
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tubular-heated milks the b* value was shown to increase with increasing final heat 
temperature, while injection-treated milks did not. Increases in b* values can result from the 
occurrence of Maillard browning in a system (Morales and van Boekel, 1998). The increased 
b* values in tubular- and injection- treated formulations indicates a greater level of Maillard 
browning compared to that in infusion- treated formulations.  
Euclidean distance, ΔE, provides information on the overall colour change from the unheated 
formulation for each of the heat-treated protein-enriched beverages (Table 2). Protein 
concentration, heating technology and final heat temperature all significantly affected the ΔE 
(p < 0.001, for each factor in terms of three-way ANOVA). Tubular heating resulted in the 
greatest overall colour change, particularly at 6 and 8% protein, and all heating temperatures 
resulted in a visibly observable colour difference (ΔE > 2.3). It should be noted that these 
colour changes are not thought to be of an order of magnitude that would be undesirable from 
a consumer perspective. 
4. Conclusion 
Supersonic steam injection heating provides substantial retention of native whey protein, 
particularly heat labile β-lg, across three ESL and UHT temperatures, compared to traditional 
tubular and direct steam infusion heating. Physical characteristics such as viscosity, particle 
size and accelerated storage stability did not significantly differ between the differently heat-
treated formulations. It is well established that direct heating imparts less thermal damage on 
a product than indirect heating; however, the more novel supersonic direct steam injection 
technology provides an opportunity to further reduce thermal damage of dairy beverages, 
particularly in terms of protein denaturation. The application of this technology could enable 
opportunities differentiated product characteristics in long-life ready-to-drink high-protein 
beverages with high levels of native whey protein. 
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Appendix I 
The ratio of steam to product, on a water basis, required to achieve the desired increase in 
product temperature, ΔT, can be calculated as:  
  
    
     
                                A.1 
where h1 is the specific enthalpy of the steam at the nozzle inlet, hf is the specific enthalpy of 
the product at the final temperature and cp is the specific heat of the product; the value of cp is 
made up of contributions from water (the major component) and also of fat and non-fat 
solids. If the incoming product is preheated, to Ti = 70 °C, with a typical final heat 
temperature, Tf = 121 °C, after mixing with steam at 3 bar(a), the ratio of condensed steam to 
incoming product to achieve the desired product temperature (121 °C) is 9. 5% by weight.  
The thermodynamic conditions in the supersonic steam injector unit were analysed to 
understand the thermodynamic conditions in the deLaval nozzle. While the mass flowrate is 
constant at successive sections of the nozzle, the volumetric flowrate changes as it goes 
through, mainly for two reasons (i) the cross-sectional area is changing, and (ii) steam is 
being condensed as it moves through the nozzle. The percentage of the total steam load that is 
condensed before the throat is not known and hence in the simulation this percentage is 
treated as an arbitrary constant which can be set between 0 and 100%. The velocity profile 
for steam at successive sections can be described by the steady flow enthalpy equation, based 
on the law of conservation of energy as applied to compressible fluids: 
     
         
                A.2 
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where h is the specific enthalpy of steam and v is the velocity of fluid flow. For cases in 
which v1 is very small in comparison to v2, v1 may be neglected (Gupta, 2013), resulting in the 
equation: 
                                      A.3 
 
For a system using saturated steam supply (6 bar (a)) at nozzle inlet (1) and throat (2) 
pressure of 3 bar (a), we obtain using saturated steam tables, h1 = 2756 kJ⁄kg, and near 
supersonic conditions, using wet steam tables, h2= 2639 kJ⁄kg, giving 
                 
The Mach number can be written as: 
    
 
 
                    A.4 
 
where c is the local speed of sound, 440 m/s. Thus, Ma at the throat is calculated as 1.1; 
however, as the flow would become choked at the throat, to a maximum of Ma = 1, the 
maximum throat velocity would equal c.   
If the fluid flow reaches sonic velocity at the throat, the velocity increases in the diverging 
section of the de Laval nozzle, as the area increases, as described in equation A.4 below 
(derived from the Bernoulli continuity equation), i.e. giving supersonic flow, since the 
combination of Ma  1 and dA > 0 gives dv > 0, hence increasing v:  
  
 
  
  
 
                     A.5 
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However, after supersonic flow has been achieved within the diffuser, boundary conditions 
will ensure that the velocity will eventually decrease at a point which depends on the ratio of 
inlet pressure to exit or back pressure of the injector and drop below Ma = 1 to subsonic flow. 
This irreversible adjustment of velocity results in a shock wave.  It should be noted that 
achieving this condition depends on matching the nozzle dimensions to the flow of product 
and steam, using 
                  A.6 
where Q is the volumetric flowrate of steam at the throat and A is the available cross sectional 
area, with allowance for a slight restriction due to product flow determined by the densities of 
product and steam. 
The mass flowrate of water removed from the steam-product mix, ml, by flash cooling can be 
determined by calculating the weight percent vapourised, X: 
  
      
    
  
  
    
       A.7 
where h
L
 is the liquid enthalpy upstream (u) and downstream (d) from the flash cooler, and h
v
 
is the vapour enthalpy at the flash cooler. 
The mass flowrate of vapourised liquid in the flash cooler, ml, can be determined using: 
     
  
                     A.8 
Best operating practices of direct heating systems recommend that the flash cooling system is 
operated so that the flash cooling temperature is equal to the preheat temperature used 
(Burton, 1968).  For a product at 121 °C where the flash cooler is operated at 0.3 bar(a) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
26 
 
resulting in a flash cooling temperature of 70 °C, the mass flowrate of liquid being removed 
from the flash cooler can be calculated as: 
         
               
Note that there is still a differential between the calculated values for ms and ml, which may 
result in a 2.98 % concentration of the product despite ideal operating conditions. As 
described by Burton and Lewis (2009), the total solids of the product should be monitored for 
dilution or concentration and the temperature of the flash cooler adjusted if required, as 
dilution of product is commonly reported in pilot-scale operation of direct heating systems 
(Dickow et al., 2012b; Murphy et al., 2013; Dumpler et al., 2017).  For the SSIH system, 
increasing the flash cooling pressure to 0.6 bar(a), related to a temperature of 86 °C, could 
limit the change in product solids to a dilution of 0.16 %. However, for flash cooler operation 
at 0.3 bar(a), a simple mass balance can determine the quantity of product leaving the flash 
cooler to be 97 kg/h. 
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Tables  
Table 1. Physico-chemical characteristics of protein-enriched skim milk beverage 
formulations at 4, 6, and 8% protein before and after heat treatment with direct infusion, 
direct injection or indirect tubular heat treatment at a preheat temperature of 70°C for 30 s 
and final heat temperatures of 121, 135 and 142°C for 3s.
1
 
 
Treatment 
pH Total Solids Total Protein Viscosity 
Particle 
Size 
 
Technology Temp - % (w/w) % (w/w) m.Pas 
diameter
2
  
(nm)
 
4
%
 P
ro
te
in
 
Unheated  6.74 ± 0.05
a
 10.3 ± 0.09
a 
4.02 ± 0.16
ab
 3.86 ± 0.12
a 
222 ± 8
a 
Infusion 
121 6.75 ± 0.05
a
 9.15 ± 0.09
b 
3.82 ± 0.05
bc 
3.83 ± 0.06
a
 220 ± 11
a 
135 6.75 ± 0.07
a
 9.09 ± 0.00
b 
3.74 ± 0.03
c 
3.86 ± 0.14
a
 212 ± 1
a 
142 6.76 ± 0.06
a
 8.94 ± 0.14
b 
3.73 ± 0.07
c 
3.86 ± 0.04
a
 211 ± 2
a 
Injection 
121 6.68 ± 0.02
a
 10.1 ± 0.01
a 
3.95 ± 0.06
abc
 3.64 ± 0.09
a
 238 ± 4
a 
135 6.68 ± 0.02
a
 10.0 ± 0.0
a 
3.92 ± 0.03
abc
 3.72 ± 0.05
a
 222 ± 9
a 
142 6.68 ± 0.01
a
 10.1 ± 0.02
a 
3.93 ± 0.01
abc
 3.67 ± 0.03
a
 280 ± 9
a
 
Tubular 
121 6.76 ± 0.06
a
 10.1 ± 0.08
a 
3.99 ± 0.19
abc
 3.82 ± 0.10
a
 205 ± 1
a 
135 6.74 ± 0.06
a
 10.1 ± 0.08
a 
4.13 ± 0.05
a
 3.73 ± 0.17
a
 214 ± 8
a 
142 6.74 ± 0.05
a
 10.1 ± 0.03
a 
4.09 ± 0.05
ab
 3.82 ± 0.07
a
 230 ± 10
a 
6
%
 P
ro
te
in
 
Unheated  6.73 ± 0.06
a 
12.3 ± 0.13
a 
5.81 ± 0.63
abc 
4.33 ± 0.16
a 
291 ± 75
a 
Infusion 
121 6.73 ± 0.09
a 
11.5 ± 0.12
b 
5.51 ± 0.08
abc 
4.21 ± 0.21
a
 238 ± 6
a 
135 6.73 ± 0.08
a
 11.1 ± 0.05
bc 
5.41 ± 0.16
c 
4.10 ± 0.02
a
 230 ± 8
a 
142 6.73 ± 0.06
a
 11.0 ± 0.13
c 
5.41 ± 0.09
bc 
4.36 ± 0.12
a 
 231 ± 10
a 
Injection 
121 6.64 ± 0.02
a
 12.1 ± 0.03
a 
5.95 ± 0.01
abc 
4.25 ± 0.06
a
 259 ± 4
a 
135 6.64 ± 0.02
a
 12.1 ± 0.03
a
 5.95 ± 0.01
abc 
4.19 ± 0.04
a
 250 ± 1
a 
142 6.64 ± 0.01
a
 12.1 ± 0.06
a
 5.95 ± 0.04
abc 
4.27 ± 0.06
a 
282 ± 8
a 
Tubular 121 6.72 ± 0.08
a
 12.2 ± 0.09
a
 5.93 ± 0.29
a 
4.11 ± 0.14
a 
227 ± 26
a 
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135 6.71 ± 0.08
a
 12.1 ± 0.25
a
 5.88 ± 0.16
abc 
4.18 ± 0.06
a
 269 ± 48
a 
142 6.67 ± 0.07
a
 12.1 ± 0.12
a  
 5.91 ± 0.20
abc 
4.32 ± 0.05
a
 272 ± 12
a 
8
%
 P
ro
te
in
 
Unheated  6.69 ± 0.06
a 
14.5 ± 0.12
a 
7.75 ± 0.38
a 
6.66 ± 1.33
a 
366 ± 14
a 
Infusion 
121 6.70 ± 0.08
a 
12.8 ± 0.28
b 
7.29 ± 0.30
a 
4.69 ± 0.52
b 
286 ± 6
bc 
135 6.72 ± 0.06
a 
12.8 ± 0.29
b 
7.25 ± 0.23
a 
4.57 ± 0.45
b 
284 ± 26
bc 
142 6.72 ± 0.06
a 
12.7 ± 0.27
b 
7.34 ± 0.20
a 
4.66 ± 0.06
b 
286 ± 10
bc 
Injection 
121 6.62 ± 0.01
a 
14.5 ± 0.06
a 
7.88 ± 0.08
a 
4.59 ± 0.13
b 
282 ± 17
bc 
135 6.62 ± 0.00
a 
14.4 ± 0.07
a 
7.85 ± 0.03
a 
4.94 ± 0.48
b 
250 ± 6
c 
142 6.63 ± 0.00
a 
14.2 ± 0.06
a 
7.82 ± 0.07
a
 4.66 ± 0.13
b 
316 ± 20
ab 
Tubular 
121 6.72 ± 0.06
a 
14.4 ± 0.20
a 
7.68 ± 0.47
a 
5.15 ± 0.19
b 
274 ± 20
bc 
135 6.69 ± 0.06
a 
14.4 ± 0.19
a 
7.73 ± 0.44
a 
4.88 ± 0.43
b 
289 ± 13
bc 
142 6.65 ± 0.05
a 
14.2 ± 0.08
a 
7.70 ± 0.51
a 
4.79 ± 0.26
b 
284 ± 13
bc 
 
1
 For each formulation (protein concentration), mean values with a common superscript letter 
in the same column are not significantly different (p > 0.05).  
2
 Average particle size is presented in terms of intensity mean. 
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Table 2. Colour analysis of protein–enriched skim milks at 4, 6 and 8 % protein (w/w) before 
and after heat treatment with direct infusion, direct injection or indirect tubular heat treatment 
at a preheat temperature of 70°C for 30 s and final heat temperatures of 121, 135 and 142°C 
for 3s. 
 
 Tech. Temp.  
(°C) 
L* a* b* ΔE 
4
%
 P
ro
te
in
 
Unheated  75.44 ± 1.12
a
 -5.32 ± 0.16
c
 -0.23 ± 0.20
d
   
Infusion 121 75.54 ± 1.51
a
 -4.75 ± 0.05
ab
 -0.17 ± 0.17
d
 0.91 ± 0.18
c
 
135 76.15 ± 1.39
a
 -4.86 ± 0.03
ab
 -0.18 ± 0.39
d
 0.92 ± 0.28
c
 
142 76.95 ± 0.89
a
 -5.06 ± 0.18
abc
 0.18 ± 0.10
d
 1.64 ± 0.29
c
 
Injection 121 75.81 ± 0.13
a
 -5.08 ± 0.02
abc
 2.62 ± 0.04
ab
 2.89 ± 0.09
b
 
135 76.09 ± 0.39
a
 -5.05 ± 0.07
abc
 2.71 ± 0.02
ab
 3.11 ± 0.24
b
 
142 76.52 ± 0.05
a
 -5.05 ± 0.03
abc
 2.87 ± 0.02
ab
 3.35 ± 0.09
b
 
Tubular 121 77.07 ± 1.04
a
 -5.18 ± 0.07
bc
 0.43 ± 0.27
cd
 1.77 ± 0.07
c
 
135 77.75 ± 1.03
a
 -5.17 ± 0.10
bc
 1.68 ± 0.46
bc
 3.01 ± 0.45
b
 
142 78.80 ± 1.42
a
 -4.70 ± 0.25
a
 3.32 ± 0.73
a
 4.95 ± 0.62
a
 
6
%
 P
ro
te
in
 
Unheated  78.08 ± 1.16
b
 -5.05 ± 0.56
b
 1.56 ± 0.43
c
   
Infusion 121 78.64 ± 0.58
b
 -4.72 ± 0.19
ab
 3.00 ± 1.11
bc
 2.26 ± 1.56
b
 
135 78.70 ± 0.48
b
 -4.63 ± 0.21
ab
 2.75 ± 0.97
bc
 2.15 ± 1.40
b
 
142 80.20 ± 1.37
ab
 -4.66 ± 0.08
ab
 2.65 ± 0.44
bc
 2.34 ± 0.67
b
 
Injection 121 78.06 ± 0.13
b
 -4.82 ± 0.01
ab
 4.08 ± 0.00
abc
 2.16 ± 0.18
b
 
135 78.93 ± 0.04
ab
 -4.74 ± 0.03
ab
 4.48 ± 0.13
abc
 3.13 ± 0.14
ab
 
142 79.12 ± 0.13
ab
 -4.62 ± 0.00
ab
 4.71 ± 0.14
ab
 3.41 ± 0.26
ab
 
Tubular 121 80.58 ± 1.26
ab
 -4.24 ± 0.92
ab
 3.49 ± 1.00
bc
 3.26 ± 1.41
b
 
135 81.40 ± 1.33
ab
 -3.86 ± 1.00
ab
 5.12 ± 1.30
ab
 5.08 ± 1.77
ab
 
142 82.85 ± 1.07
a
 -2.57 ± 1.07
a
 7.25 ± 1.07
a
 7.95 ± 2.49
a
 
8 %
 
P
r
o
t ei n
 Unheated  80.20 ± 0.44
c
 -5.36 ± 0.18
c
 2.82 ± 0.40
e
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Infusion 121 81.81 ± 1.19
abc
 -4.54 ± 0.08
b
 3.71 ± 0.41
d
 2.75 ± 0.62
d
 
135 82.08 ± 1.20
abc
 -4.52 ± 0.09
b
 3.84 ± 0.29
d
 3.31 ± 0.78
cd
 
142 82.28 ± 1.20
abc
 -4.39 ± 0.04
b
 4.28 ± 0.28
cd
 3.77 ± 0.74
bc
 
Injection 121 80.14 ± 0.27
c
 -4.51 ± 0.02
b
 5.22 ± 0.16
bc
 1.36 ± 0.42
e
 
135 80.72 ± 0.08
bc
 -4.38 ± 0.04
b
 5.58 ± 0.10
b
 2.03 ± 0.03
de
 
142 80.92 ± 0.22
bc
 -4.26 ± 0.02
b
 5.85 ± 0.19
b
 2.38 ± 0.43
cde
 
Tubular 121 81.90 ± 0.80
abc
 -4.79 ± 0.16
b
 4.13 ± 0.34
cd
 2.90 ± 0.37
cd
 
135 82.57 ± 0.78
ab
 -4.44 ± 0.38
b
 5.53 ± 0.80
b
 3.95 ± 0.09
b
 
142 84.04 ± 1.40
a
 -3.72 ± 0.57
a
 7.11 ± 1.22
a
 5.87 ± 0.55
a
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Figures 
Fig. 1. Process flow diagram of (A) direct steam infusion, (B) direct steam injection and (C) 
indirect tubular heat exchange pilot plants across preheating, final heating, initial and final 
cooling operations.  Common preheat and final cooling operations are used for the direct 
injection and indirect tubular plants (----).  
 
Fig. 2. Levels of native (a) α-la, (b) β-lg A and (c) β-lg B protein in 4, 6, and 8% protein 
(w/w) formulations heat-treated using direct steam infusion (■), direct steam injection (■) 
and indirect tubular heating (■) at final heat temperatures of 121, 135 and 142 °C, expressed 
as a percentage of the respective native protein content of the unheated formulation. The error 
bars represent the standard error determined from three trial replicates.  
 
Fig. 3. Particle size distribution, on an intensity basis, of unheated ( ) beverages, and 
infusion ( ), injection ( ), and tubular ( ) heated 4% (w/w) protein formulation at final 
heat temperatures of (A) 121, (B) 135 and (C) 142 °C.  
 
Fig. 4. Instability index of formulations, following accelerated storage stability using an 
analytical centrifuge at 2300 x g, for 3h at 25°C, with 4 (■), 6 (■), and 8% (■) protein (w/w) 
before and after heat treatment with direct infusion, direct injection or indirect tubular heat 
treatment at final heat temperatures of 121, 135 and 142 °C for 3 s. 
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Highlights 
Supersonic steam injection provides rapid heating and high shear 
Substantial native whey protein retention compared to tubular and infusion heating 
No difference in accelerated physical stability for heating technologies 
May enable new product development opportunities 
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